» Articles » PMID: 32265633

Neuronal CXCL10/CXCR3 Axis Mediates the Induction of Cerebral Hyperexcitability by Peripheral Viral Challenge

Overview
Journal Front Neurosci
Date 2020 Apr 9
PMID 32265633
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral infections can potently exacerbate neuropathological conditions, though the underlying mechanisms are poorly understood. We have previously demonstrated that intraperitoneal (i.p.) injection of a viral mimetic, polyinosinic-polycytidylic acid (PIC) induces a robust generation of CXCL10 chemokine in the hippocampus. The hippocampus also features hyperexcitability of neuronal circuits following PIC challenge. The present study was undertaken to determine the role of CXCL10 in mediating the development of hyperexcitability in response to PIC challenge. Briefly, young female C57BL/6 mice were i.p. injected with PIC, and after 24 h, the brains were analyzed by confocal microscopy. CXCL10 staining of neuronal perikarya and a less intense staining of the neuropil was observed in the hippocampus and cortex. CXCL10 staining was also evident in a subpopulation of astrocytes, whereas microglia were CXCL10 negative. CXCR3, the cognate receptor of CXCL10 was present exclusively on neurons, indicating that the CXCL10/CXCR3 axis operates through an autocrine/paracrine neuronal signaling. Blocking cerebral CXCR3 through intracerebroventricular injection of a specific inhibitor, AMG487, abrogated PIC challenge-induced increase in basal synaptic transmission and long-term potentiation (LTP), as well as the reduction of paired-pulse facilitation (PPF), in the hippocampus. The PIC-mediated abolishment of hippocampal long-term depression (LTD) was also restored after administration of AMG487. Moreover, CXCR3 inhibition attenuated seizure hypersensitivity induced by PIC challenge. The efficacy of AMG487 strongly strengthens the notion that CXCL10/CXCR3 axis mediates the induction of cerebral hyperexcitability by PIC challenge.

Citing Articles

CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson's disease models.

Leser F, Junyor F, Pagnoncelli I, Delgado A, Medeiros I, Nobrega A J Neuroinflammation. 2025; 22(1):31.

PMID: 39894839 PMC: 11789347. DOI: 10.1186/s12974-024-03318-x.


Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters.

Rajaiah R, Pandey K, Acharya A, Ambikan A, Kumar N, Guda R iScience. 2024; 27(8):110501.

PMID: 39171289 PMC: 11338146. DOI: 10.1016/j.isci.2024.110501.


SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer's Disease.

Vavougios G, Mavridis T, Doskas T, Papaggeli O, Foka P, Hadjigeorgiou G Curr Issues Mol Biol. 2024; 46(5):4565-4579.

PMID: 38785545 PMC: 11119810. DOI: 10.3390/cimb46050277.


CXCL10 is a crucial chemoattractant for efficient intranasal delivery of mesenchymal stem cells to the neonatal hypoxic-ischemic brain.

Hermans E, Donega V, Heijnen C, de Theije C, Nijboer C Stem Cell Res Ther. 2024; 15(1):134.

PMID: 38715091 PMC: 11077865. DOI: 10.1186/s13287-024-03747-8.


Type I interferon signaling, cognition and neurodegeneration following COVID-19: update on a mechanistic pathogenetic model with implications for Alzheimer's disease.

Vavougios G, Tseriotis V, Liampas A, Mavridis T, de Erausquin G, Hadjigeorgiou G Front Hum Neurosci. 2024; 18:1352118.

PMID: 38562226 PMC: 10982434. DOI: 10.3389/fnhum.2024.1352118.


References
1.
Ben-Ari Y, Cossart R . Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 2000; 23(11):580-7. DOI: 10.1016/s0166-2236(00)01659-3. View

2.
Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, Nolte C . CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci. 2004; 24(39):8500-9. PMC: 6729901. DOI: 10.1523/JNEUROSCI.2451-04.2004. View

3.
Michalovicz L, Lally B, Konat G . Peripheral challenge with a viral mimic upregulates expression of the complement genes in the hippocampus. J Neuroimmunol. 2015; 285:137-42. PMC: 4673984. DOI: 10.1016/j.jneuroim.2015.06.003. View

4.
Anderson W, Collingridge G . Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J Neurosci Methods. 2007; 162(1-2):346-56. DOI: 10.1016/j.jneumeth.2006.12.018. View

5.
Kirschman L, Borysiewicz E, Fil D, Konat G . Peripheral immune challenge with dsRNA enhances kainic acid-induced status epilepticus. Metab Brain Dis. 2011; 26(1):91-3. DOI: 10.1007/s11011-011-9236-z. View